Evercore ISI Group analyst Stephen Richardson downgrades Occidental Petroleum (NYSE:OXY) from In-Line to Underperform and lowers the price target from $74 to $60.
Goldman Sachs Maintains Sell on TG Therapeutics, Raises Price Target to $6
Goldman Sachs analyst Corinne Jenkins maintains TG Therapeutics (NASDAQ:TGTX) with a Sell and raises the price target from $4 to $6.